| P2093 | author name string | Andrew Clark | |
| | Stephen Newman | |
| | Gary Pitcairn | |
| | Mei-Chang Kuo | |
| | Peter Hirst | |
| | Matt Pickford | |
| P2860 | cites work | The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols | Q33280151 |
| | Clinical pharmacokinetics and pharmacodynamics of inhaled insulin | Q35881751 |
| | Pressurised aerosol deposition in the human lung with and without an "open" spacer device | Q36205932 |
| | Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancers | Q36711774 |
| | Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats | Q36803457 |
| | Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers | Q42603342 |
| | EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin | Q46581631 |
| | Determination of nebulizer droplet size distribution: a method based on impactor refrigeration | Q47285870 |
| | Permeability of the respiratory tract to different-sized macromolecules after intratracheal instillation in young and adult rats | Q68849870 |
| | Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats | Q72746299 |
| | Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit | Q72834290 |
| | Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung | Q73272611 |
| P433 | issue | 7 | |
| P921 | main subject | aerosol | Q104541 |
| | bioavailability | Q461809 |
| P304 | page(s) | 1583-1590 | |
| P577 | publication date | 2008-02-21 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin | |
| P478 | volume | 25 | |